Delcath Systems DCTH
NASDAQ DCTH
$15.98 -0.10 (-0.62%)
At close: Sep 9, 2026 · 4:00 PM EDT

Delcath Systems (DCTH) Cash from Investing Activities (2010 - 2026)

Delcath Systems (DCTH) posted Cash from Investing Activities of -$504000.0 for Q2 2026, up 11.73% on a QoQ basis from -$571000.0 in Q1 2026, and down 21.45% year-over-year from -$641595.1 in Q2 2025.

Analysis

Delcath Systems (DCTH) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Delcath Systems has reported Cash from Investing Activities for 17 years, with the latest figure at -$504000.0 in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities fell 21.45% year-over-year to -$504000.0 in Q2 2026; TTM through Jun 2026 was -$2.1 million, a 94.93% increase from a year earlier, with the FY2025 full-year figure at -$26.6 million, down 2610.5% from the prior year.
  • Cash from Investing Activities was -$504000.0 for Q2 2026 at Delcath Systems, up from -$571000.0 in the prior quarter.
  • The five-year high for Cash from Investing Activities was $10.3 million in Q2 2024, with the low at -$25.1 million in Q1 2025.
  • Average Cash from Investing Activities over 5 years is -$3.0 million, with a median of -$440500.0 recorded in 2025.
  • The largest YoY upside for Cash from Investing Activities was 25810.0% in 2024 against a maximum downside of 69800.0% in 2024.
  • Over 5 years, Cash from Investing Activities stood at -$68000.0 in 2022, then slumped by 28826.47% to -$19.7 million in 2023, then increased by 22.58% to -$15.2 million in 2024, then surged by 96.32% to -$561000.0 in 2025, then grew by 10.16% to -$504000.0 in 2026.
  • The last three Cash from Investing Activities figures came in at -$504000.0 (Q2 2026), -$571000.0 (Q1 2026), and -$561000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -673.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -26.60 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -1.62 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -639.00 Mn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn -1.96 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn -193.20 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -222.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 329.80 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -108.50 Mn
10 Delcath Systems 575.53 Mn 479.61 Mn 26.15 Mn -504,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -504,000.00
Mar 31, 2026 -571,000.00
Dec 31, 2025 -561,000.00
Sep 30, 2025 -466,000.00
Jun 30, 2025 -415,000.00
Mar 31, 2025 -25.15 Mn
Dec 31, 2024 -15.23 Mn
Sep 30, 2024 -697,000.00
Jun 30, 2024 10.28 Mn
Mar 31, 2024 4.66 Mn
Dec 31, 2023 -19.67 Mn
Sep 30, 2023 1,000.00
Jun 30, 2023 -40,000.00
Sep 30, 2022 -68,000.00
Jun 30, 2022 -52,000.00
Mar 31, 2022 -89,000.00
Dec 31, 2021 1,000.00
Sep 30, 2021 -56,000.00
Jun 30, 2021 -79,000.00
Mar 31, 2021 -9,000.00